December 5th, 2022 Cambridge, MA—Portal Instruments is pleased to announce the appointment of Dr. Veena Rao, PhD,  as Chief Business Officer, effective December 5th, 2022. Dr. Rao will lead the identification, evaluation, and negotiation of partnership opportunities for Portal.  In addition, Dr. Rao, in close collaboration with the CEO and cross-functional team, will guide the company’s short and long-term commercial strategy.  She will report directly to the company CEO, Dr. Patrick Anquetil.


“Veena brings to Portal extensive experience launching products and building commercial organizations in the pre-launch and early launch phases,” said Anquetil. “Her background and deep knowledge of the medical device, pharma, biotech, and digital health spaces will be influential in shaping the future of Portal.” 


Rao joins Portal most recently from Beta Bionics where she was Chief Commercial Officer and Head of Corporate Development & Strategy.  In that role, she led the commercial team and was responsible for the go-to-market strategy. Prior to Beta Bionics, Rao spent over a decade working for Eli Lilly in a number of commercial and technical roles including Vice President of External Innovation in the Lilly Device, Delivery, and Digital Health groups.   Rao has a PhD in Chemical Engineering from Stanford University and an MBA from the University of Virginia Darden School of Business.


“It is a true honor to be joining Portal and having the opportunity to bring this innovative technology to market with such a highly talented and passionate team.” .


About Portal Instruments

Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Real time tracking and reporting sets a new standard for monitoring adherence and potentially improving patient outcomes. Portal Instruments is ISO 13485:2016 certified. For more information, please visit: or follow @portalcambridge on Twitter.



Dr. Patrick Anquetil

Chief Executive Officer